Skinvisible has fourteen patents granted, including comprehensive patents on Invisicare, the foundation of all of our products; three in the US, and internationally in Canada, Europe (4), China, India, Australia, Hong Kong, Japan and Korea. The Invisicare patents cover manufacturing, composition and use. Additionally, Skinvisible has been granted three product specific patents in the US for dermal barrier products, sunscreens (photostability of avobenzone) and retinoids (stabilization). There are a number of U.S. and international (PCT) patents pending, with many more patent applications in progress. Some of these patents cover up to five products.

Skinvisible's value lies in its ability to continually generate new IP on dermatology and medical products formulated with Invisicare. Patent approvals are sought (initially in the U.S. and later internationally) for all products developed. All patents with Invisicare are owned by Skinvisible.

Patent Components (Combined or Individually):

Granted Patents

United States Patents Granted

United States Patent No.: 8,318,818
Granted: November 27, 2012 (1420 day extension)
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Patent No.: 7,674,471
Granted: Granted: March 9, 2010 (921 day extension)
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Patent No.: 6,756,059
Granted: June 29, 2004
Topical composition, topical composition precursor, and methods for manufacturing and using.

United States Invisicare Product Patents Granted

United States Patent No.: 8,299,122
Granted: October 30, 2012
Method for stabilizing retinoic acid, retinoic acid containing composition, and method of using a retinoic acid containing composition.

United States Patent No.: 8,128,913
Granted: March 6, 2012
Sunscreen composition with enhanced UV-A absorber stability and methods.

United States Patent No.: 6,582,683
Granted: June 24, 2003
Dermal barrier composition.

International Patents Granted

India Patent
Granted: July 26, 2007
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Australia Patent
Granted: June 3, 2008
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

China Patent
Granted: July 1, 2009
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Korea Patent
Granted: February 9, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Hong Kong Patent
Granted: July 27, 2010
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Canada Patent
Granted: February 22, 2011
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

European Patent(4)
Granted: September, 2011
Topical Composition, Topical Composition Precursor, and Methods for Manufacturing and Using.

Latest Press Releases:

December 4, 2012
Skinvisible Granted US Patent for Topical Drug Delivery Technology - Invisicare® Patent Protection Extends to Year 2029

November 27, 2012
Skinvisible Granted US Patent for Stabilizing Retinoids - Intellectual Property Portfolio Strengthens

June 28, 2012
Skinvisible's Hand Sanitizer Kills "Super Bug" MRSA and E. coli For Up to 4 Hours - Studies Confirm One Application of DermSafe As An Effective Long-Lasting Hand Sanitizer

April 12, 2012
Skinvisible Licensee Increases US Sales for Women's Health Product Made with Invisicare - ProCort® Distribution Expands to Puerto Rico

March 7, 2012
Skinvisible Granted US Sunscreen Patent for UVA Absorber - Broad Spectrum UVA / UVB Sunscreens with Invisicare Offer Eight Hours of Photostability

February 23, 2012
Skinvisible Formulation Submitted to European Union for Orphan Drug Designation - Invisicare Formulation for Netherton Syndrome Under Review

CLICK HERE TO READ ALL NEWS RELEASES

Research & Development

Technology Overview